Journal of Korean Medicine Rehabilitation (한방재활의학과학회지)

The society of Korean Medicine Rehabilitation (한방재활의학과학회)
권호 표지

Effects of Stem Bark Extracts of Cornus walteri Wanger on the Lipid Lowering, Anti-oxidative Activity and Concentration of Proinflammatory Cytokines in Rat Fed High Fat Diet

모래지엽(毛棶枝葉)(Cornus walteri Wanger) 추출물이 비만 쥐의 지질강하, 항산화효과 및 전염증성 cytokines 농도에 미치는 영향

  • Park, Won-Hyung (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Sang-Ji University) ;
  • Cha, Yun-Yeop (Dept. of Oriental Rehabilitation Medicine, College of Oriental Medicine, Sang-Ji University)
  • 박원형 (상지대학교 한의과대학 한방재활의학과교실) ;
  • 차윤엽 (상지대학교 한의과대학 한방재활의학과교실)
  • Received : 2009.09.15
  • Accepted : 2009.10.16
  • Published : 2009.10.31

⟨ Previous Next ⟩

Abstract

Objective : This study was designed to examine the effects of stem bark extracts of Cornus walteri Wanger on the lipid lowering, anti-oxidative activity and concentration of proinflammatory cytokines in hyperlipidemic rat. Methods : Male rats weighing $195.21{\pm}5.85g$ fed high fat diet for 8 weeks and 40 rats(above 400 g) were divided into 4 groups. Each groups were divided into a control group and 3 experimental groups. We fed a control group of rats a basal diet and administered normal saline(100 mg/kg, 1 time/1 day) for 4 weeks. And we fed each experimental group of rats Basal diet and administered an extract of Cornus walteri Wanger(100 mg/kg, 200 mg/kg, 300 mg/kg, 1 time/1 day) for 4 weeks. At the end of the experiment, the rats were sacrificed to determine their chemical composition. We measured lipid of plasma and liver, concentration of proinflammatory cytokines, anti-oxidative activity and gene expression. Results : 1. Concentration of plasma free fatty acid, LDL-cholesterol showed a tendency to decrease in Cornus walteri Wanger ext. groups. Concentration of plasma triglyceride, total cholesterol showed a significantly decrement in all Cornus walteri Wanger ext. group than that of control group. HDL-cholesterol showed a significantly increment in the 300 mg/kg Cornus walteri Wanger ext. group. 2. Concentration of liver total cholesterol showed a tendence to decrease in Cornus walteri Wanger ext. groups. Concentration of triglyceride liver showed a significantly decrement in all Cornus walteri Wanger ext. group than that of control group. 3. Concentration of plasma and liver TBARS showed a tendence to decrease in Cornus walteri Wanger ext. groups. The values of GSH-Px, SOD and CAT activity showed a significantly increment in the 300 mg/kg Cornus walteri Wanger ext. group than that of control group. 4. The values of plasma AST and ALT activity showed no significantly different in all treatment groups. 5. Concentration of plasma $IL-1{\beta}$, IL-6 and $TNF-{\alpha}$ showed a tendency to decrease in the Cornus walteri Wanger ext. groups. However the concentration of IL-10 in the 200 and 300 mg/kg Cornus walteri Wanger ext. groups showed a significantly increment than that of control group. Concentration of liver $IL-1{\beta}$, $TNF-{\alpha}$ and IL-10 showed no significantly difference in all treatment groups. However concentration of IL-6 in the 200 and 300 mg/kg Cornus walteri Wanger ext. groups showed a significantly decrement than that of control group. 6. In the analysis of RT-PCR, gene expression of $TNF-{\alpha}$, Apo-B, Apo-E and leptin in the Cornus walteri Wanger ext. groups showed a lower expression than that of control group. 7. The ratio of $TNF-{\alpha}$, Apo-E and leptin expression per $\beta$-actin expression in the 200 and 300 mg/kg Cornus walteri Wanger ext. showed a significantly decrement than that of control group. The ratio of Apo-B expression per $\beta$-actin expression in the 300 mg/kg Cornus walteri Wanger ext. showed a significantly decrement than that of control group. Conclusions : According to above results, in lowering lipid effect, antioxidative activity and antiinflammatory effect, the Cornus walteri Wanger ext. gives positive effect.

Keywords

References

  1. 한방재활의학과학회. 한방재활의학과학. 서울:군자출판사. 2003:349, 357-9, 393-6.
  2. 대한비만학회. 임상비만학. 서울:고려의학. 2001:24-6, 115-6.
  3. 비만관리를 위한 건강길잡이. 서울:한미의학. 2003:29-57.
  4. 대한일차의료학회 비만연구회 편. 비만학 이론과 실제. 서울:한국의학. 1996:267.
  5. 洪元植. 精校黃帝內經. 서울:東洋醫學硏究院出版部. 1991:61, 94, 219.
  6. 허수영, 강효신. 비만의 동서의학적 고찰과 치료. 한방재활의학회지. 1997;7(1):272-86.
  7. 황미자, 신현대, 송미연. 2000년 이후 비만치료에 사용되는 處方및 本草에 대한 문헌 연구. 대한한방비만학회지. 2007;7(1):39-54.
  8. Barker J, Liu JP, Robertson EJ, Estratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75(1):73-82. https://doi.org/10.1016/S0092-8674(05)80085-6
  9. Hill JO, Lin D, Yakybu F, Peters JC. Development of dietary obesity in rats :i nfluence of amount and composition of dietary fat. Int J Obes Relat Metab Disord. 1992;16(5):321-33.
  10. Weigle DS. Appetite and the regulation of body composition. FASEB J. 1994;8(3):302-10.
  11. Nielsen S, Jensen MD. Obesity and cardiovascular disease is body structure a factor. Curr Opin Lipidol. 1997;8(4):200-4. https://doi.org/10.1097/00041433-199708000-00002
  12. Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia. 1976;12(6):563-71. https://doi.org/10.1007/BF01220632
  13. Mohamed-Ali V, Goodrick S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-${\alpha}$, in vivo. J Clin Endocrinol Metab. 1997;82:4196-200. https://doi.org/10.1210/jc.82.12.4196
  14. Mohamed-Ali V, Goodrick S, Coppack SW. Adipose tissue an asendocrine and paracrine organ. Int J Obes. 1998;22:1145-58. https://doi.org/10.1038/sj.ijo.0800770
  15. Lee KU, Lee HK, Koh CS, Min HK. Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance inman. Diabetologia. 1988;31(5):285-90.
  16. Bray GA. Obesity increase risk for diabetes. Int J Obes Relat Metab Disord. 16(Suppl). 1992;4:S13-7.
  17. Hotamisligil Gs, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-${\alpha}$: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91. https://doi.org/10.1126/science.7678183
  18. Ronald M, Krauss, Mary W. Obesity : Impact on cardiovascular disease. Circulation. 1998;98 :1472-6. https://doi.org/10.1161/01.CIR.98.14.1472
  19. Robert HE. Ronald M. Krauss. American heart association call to action: Obesity as a major risk factor for coronary heart disease. Circulation. 1998;97:2099-100. https://doi.org/10.1161/01.CIR.97.21.2099
  20. 김창민. (完譯)中藥大辭典. 서울:정담.1999:1317.
  21. 옥천약용식물재배시험장. 약용식물도감. 서울:식품의약품안전본부. 1997:158.
  22. 김태정. 한국의 자원식물III. 서울:서울대학교출판부. 1996:210.
  23. 최우회, 박웅양, 황방연, 오갑진, 강신정, 이경순, 노재섭. 말채나무 수피의 페놀성 화합물. 생약학회지. 1998;29(3):217-24.
  24. 임채성, 이춘영, 김용무, 이위영, 이해익. 말채나무 추출물의 ${\alpha}$-amylase저해 활성. 한국응용생명화학회지. 2005;48(1):103-8.
  25. Buge JA, Austa SD. Microsomal lipid peroxidation. In: Methods in Enzymology. Fleicher S, Packer L.(eds). London:Academic Press. 1978;52:302-9. https://doi.org/10.1016/S0076-6879(78)52032-6
  26. Levander OA, Deloach DP, Morris VC, Moser PB. Platelet glutathione peroxidase activity asan index of selenium statusin rats. J Nutr.1983:55-63,113.
  27. Flohe L, Becker R, Brigelius R, Lengfelder E, Otting F. Convenient assays for superoxide dismutase. CRC Handbook of freeradicals and antioxidants in Biomedicine. 1992:287-93.
  28. Johnson LH, Hakan Borg LA. Aspectrophotometric method for determination of catalase activity in small tissue samples. Analytical Biochemistry. 1988:174, 331-6.
  29. 2007국민건강통계. 보건복지가족부. 2007:56.
  30. 서울대학교의과대학 내과학 교실. 내과학. 서울:군자출판사. 1996:852-62.
  31. 홍명호, 이영미, 최윤선, 김순덕. 비만의 유형과 심혈관계 질환 위험인자와의 관련성.가정의학회지. 1996;17(9):784-96.
  32. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-${\alpha}$: direct role inobesity-linked insulin resistance. Science.1993;259:87-9. https://doi.org/10.1126/science.7678183
  33. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity,diabetes,and inflammation. Circulation. 2005;111:1448-54. https://doi.org/10.1161/01.CIR.0000158483.13093.9D
  34. Graham S, Marshall J, Haughey B, Mittelman A, Swan son M, Zielezeny M, Byers T, Wilkinson G, West D. Dietary epidemiology of cancer of the colon in western New York. Am J Epidemiol. 1988;128(3):490-503. https://doi.org/10.1093/oxfordjournals.aje.a114997
  35. Jain M, Cook GM, Davis FG, Grace MG, Howe GR, Miller AB. A case-control study of dietand colorectal cancer. Int J Cancer. 1980;26(6):757-68. https://doi.org/10.1002/ijc.2910260609
  36. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehi AM. Obesity increase sensitivity to endotoin liverinjury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci. USA. 1997;94(6):2557-62. https://doi.org/10.1073/pnas.94.6.2557
  37. 洪元植譯. 校勘直譯 黃帝內經靈樞. 서울:傳統文化硏究會. 1995:284,388.
  38. 정지행, 정성희, 이종수. 비만에 관한 문헌적고찰. 동의물리요법과학회지.1992;2(1):141-55.
  39. 변진우. 비만에 대한 문헌적 고찰. 원광대학교 대학원. 석사학위 논문. 1998.
  40. 민홍규, 손영주, 심은섭, 김범회, 정혁상, 손낙원. 三黃湯이 고지방식이,MSG 및 난소적출로 유발된 흰쥐의 비만에 미치는 영향. 한방재활의학과학회지. 2008;18(1):33-46.
  41. 김효영, 허동석. 加味八物湯이 생쥐의 비만억제에 미치는 영향. 한방재활의학과학회지.2008;18(2):81-96.
  42. 송미영, 김은경, 공재철, 이정한, 신병철, 류도곤, 권강범. 고지방 식이 유도 비만에 대한 대시호탕 추출물의 억제 효과. 한방재활의학과학회지. 2008;18(3):41-9.
  43. 육창수. 원색한국약용식물도감. 서울:아카데미서적. 1993:368.
  44. 최영전. 한국민속식물. 서울:아카데미서적. 1992:107.
  45. 國家中醫藥管理局 中華本草編委會. 中華本草. 上海:上海科學技術出版社. 1999:752.
  46. 中國藥材公司. 中國中藥資源志要. 北京:科學出版社 1994:829.
  47. Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertrigly ceridaemia in man. Diabetologia.1976;12(6):563-71. https://doi.org/10.1007/BF01220632
  48. Nielsen S, Jensen MD. Obesity and cardivascular disease is body structurea factor. Curr Opin Lipidol. 1997;8(4):200-4. https://doi.org/10.1097/00041433-199708000-00002
  49. 이귀녕, 권오헌. 임상병리파일. 서울:의학문화사. 2000:148, 155-6, 164-5, 169-171, 182, 717.
  50. 한미의학 편집부 엮음. 비만관리를 위한 영양 길잡이. 서울:한미의학. 2003:30-2.
  51. 李三悅, 權五憲, 鄭允燮, 宋慶順. 임상병리검사법. 서울:연세대학교출판부. 1996:264, 283, 315.
  52. Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y, Nakatani K, Yano Y, Adachi Y. Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab. 2003;88 :4673-6. https://doi.org/10.1210/jc.2003-030202
  53. Mizuno T, Matsui H, Imamura A, Numaguchi Y, Sakai K, Murohara T, Okumura K. Insulin resistance increases circulating malondial dehyde -modified LDL and impairs endothelial function in healthy young men. Int J Cardiol. 2004;97 :455-61. https://doi.org/10.1016/j.ijcard.2003.10.035
  54. Hirai N, Kawano H, Hirashima O, Motoyama T, Moriyama Y, Sakamoto T, Kugiyama K, Ogawa H, Nakao K, Yasue H. Insulin resistance and endothelial dysfuction in smokers: effects of vitamin C. Am J Physiol Heart Circ Physiol. 2000;279:H1172-8.
  55. Bruce AF, James D, Carpo MD. Biologyof disease: Free radicals and tissue injury. Lab Invest. 1982;47:412-26.
  56. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993;90 :7915-22. https://doi.org/10.1073/pnas.90.17.7915
  57. Lioyd D. How to avoid oxygen. Science. 1999:249, 28.
  58. Singh RJ, Goss SPA, Joseph J, Kalyanaraman B. Nitration of gamma-tocopherol and oxidation of alpha-tocopherol by copper-zinc superoxid dismutase/$H_{2}O_{2}$ -:Role of nitrigen dioxide free radical. Natl Acad sci.1988;95(22):12912-7. https://doi.org/10.1073/pnas.95.22.12912
  59. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Biochemical role as a component of glutathione peroxidase. Science. 1973:179, 588. https://doi.org/10.1126/science.179.4073.588
  60. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab. 2000;26(5):387-92.
  61. Kono Y, FridovichI. Superoxide radical inhibits catalase. J Biol Chem. 1982;257(10):5751-4.
  62. Oppenheim JJ. Cytokines: past, present and future. Int J of Hematology. 2001;74(1):3-8. https://doi.org/10.1007/BF02982543
  63. 양정화. 조릿대 잎 추출물이 고지방식이 유도비만마우스의 (C57/BL6J)염증성 사이토카인과 인슐린 저항성에 미치는 영향. 전남대교육대학원. 석사학위논문. 2008.
  64. Delgado AV, McManus AT, Chambers JP. Production of tumor necrosis factor-${\alpha}$, interleukin-1${\beta}$, interleukin-2 and interleukin-6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides. 2003;37(6) :355-61. https://doi.org/10.1016/j.npep.2003.09.005
  65. Jansson JO, Walenius K, WernstedtI, Ohlsson C, Dickson SL and Walenius V. On the site and mechanism of action of the anti-obesity effects of interleukin-6. Growth Horm IGF Res. 2003;13(A);28-32. https://doi.org/10.1016/S1096-6374(03)00051-0
  66. Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P. Exercise and cytokines with particular focus on muscle derived IL-6. Immunol Rev. 2001;7:18-31.
  67. 박철영, 유형준. 염증과 비만. 대한내분비학회지. 2004;19(2):97-108.
  68. Spiegelman BM, Hotamisligil GS. Through thick and thin: wasting, obesty and TNF-${\alpha}$. Cell.1993;73(3):625-7. https://doi.org/10.1016/0092-8674(93)90243-J
  69. Hotamisligil GS. Adipose expression of tumor necrosis factor-${\alpha}$: direct role in obesity-linked insulin resistance. Science. 1993;359:87-91.
  70. Marriot JB, M Westby, S Cookson, M Guckian, S Goodbourn, G Muller. CC-3052:a water-soluble analog of thalidomide and potent inhibitoro factivation-induced TNF-${\alpha}$ production. J Immunol. 1998;161:4236-43.
  71. Zhang Y, Proenca R, Maffei M, Barone M, Leopeld L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425-32. https://doi.org/10.1038/372425a0
  72. Considine RV, Sinha MK, Heiman ML. Serum immunoreactive leptin concentration in normal -weight and obese humans. N Engl J Med. 1996;334:292-5. https://doi.org/10.1056/NEJM199602013340503
  73. Park JH. Insulin resistance in non-alcoholic fatty liver disease.J Korean hepatology. 2006;12(1):16-30.
  74. Vance DE,Vance JE. In Biochemistry of Lipids ,Lipoprotein & membrance. USA: Elsevier Science Publing Co. 1991:403-85.
  75. Rall SC Jr, Weisgraber KH, Mahley RW. Human apolipoprotein E. The complete amino acid sequence. J Biol Chem. 1982;257 :4171-8.
  76. Stiefel P, Montilla C, Muniz-Grijalvo O, Garcia -Lozano R, Alonso A, Miranda ML, Pamies E, Villar J.Apolipoprotein E gene polymorphism is related to metabolic abnormalities, but does not influence erythrocyte membrane lipid composition or sodiumlithium counter transport activity in essential hypertension. Metabolism. 2001;50:157-60. https://doi.org/10.1053/meta.2001.19429
  77. Oh JY, Barrett-Connor E. Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes. the Rancho Bernardo Study. Clin Genet. 2001;60 :132-7. https://doi.org/10.1034/j.1399-0004.2001.600207.x